Mayo Clinic seeks female volunteers over the age of 50 who have been diagnosed with osteoporosis for a research study testing a specific medication combination. The study will test the effectiveness of a medication called teriparatide (Forteo®) when given in conjunction with raloxifene (Evista®) and alendronate. The study is seeking women who have been treated with raloxifene for at least the past 18 months.
After two months of screening tests, qualified participants will be randomized to one of two medication groups: teriparatide with raloxifene or teriparatide alone. Participants must take the medications for 18 months and make about nine visits to the clinic. Compensation will be offered.
For more information, please call (904) 953-0703.